FTC sues big pharmacy reward administrators about insulin prices The company introduced action from Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the record price of lifestyle-preserving insulin medicine. This strategy aligns with People attempts, the ONC claimed. The field is tackling issues https://martinlhzvr.mybuzzblog.com/10247247/5-simple-techniques-for-healthcare-news